ATE74130T1 - Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one. - Google Patents

Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one.

Info

Publication number
ATE74130T1
ATE74130T1 AT87114724T AT87114724T ATE74130T1 AT E74130 T1 ATE74130 T1 AT E74130T1 AT 87114724 T AT87114724 T AT 87114724T AT 87114724 T AT87114724 T AT 87114724T AT E74130 T1 ATE74130 T1 AT E74130T1
Authority
AT
Austria
Prior art keywords
imidazole
dihydro
benzoyl
methyl
4ethyl
Prior art date
Application number
AT87114724T
Other languages
English (en)
Inventor
Paul William Erhardt
Iii Alfred Arthur Hagedorn
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Application granted granted Critical
Publication of ATE74130T1 publication Critical patent/ATE74130T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87114724T 1986-10-17 1987-10-08 Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one. ATE74130T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/920,086 US4743612A (en) 1986-10-17 1986-10-17 Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure
EP87114724A EP0264729B1 (de) 1986-10-17 1987-10-08 Pro-Drug-Derivate vom kardiotonischen Agenz 4-Ethyl-1,3-dihydro-5[4-(2-methyl-1H-imidazol-1-yl)-benzoyl]]-2H-imidazol-one

Publications (1)

Publication Number Publication Date
ATE74130T1 true ATE74130T1 (de) 1992-04-15

Family

ID=25443129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87114724T ATE74130T1 (de) 1986-10-17 1987-10-08 Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one.

Country Status (6)

Country Link
US (1) US4743612A (de)
EP (1) EP0264729B1 (de)
JP (1) JPS63104964A (de)
AT (1) ATE74130T1 (de)
CA (1) CA1325213C (de)
DE (1) DE3777747D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360928A (en) * 1989-10-23 1994-11-01 Research Corporation Technologies, Inc. Synthesis and use of amino acid fluorides as peptide coupling reagents
US5712418A (en) * 1989-10-23 1998-01-27 Research Corporation Technologies, Inc. Synthesis and use of amino acid fluorides as peptide coupling reagents
US5939557A (en) * 1996-04-03 1999-08-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5976069A (ja) * 1982-10-25 1984-04-28 Showa Denko Kk フタラゾン誘導体
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
DE3668450D1 (de) * 1985-03-14 1990-03-01 Smithkline Dauelsberg 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren.

Also Published As

Publication number Publication date
EP0264729B1 (de) 1992-03-25
EP0264729A2 (de) 1988-04-27
JPS63104964A (ja) 1988-05-10
DE3777747D1 (de) 1992-04-30
EP0264729A3 (en) 1989-10-11
CA1325213C (en) 1993-12-14
US4743612A (en) 1988-05-10

Similar Documents

Publication Publication Date Title
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
LU92993I2 (fr) Briviact
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
IT1264452B1 (it) 3- (acilossifenil) benzofuran-2-oni come agenti stabilizzanti
FI865257A (fi) Derivat av nya //4-/4-(4-fenyl -piperazinyl) fenoximetyl/-1,3-dioxolan-2-yl/metyl-1h-imidazoler och 1h-1,2,4-triazoler.
NO922133L (no) Substituerte diaminoftalimider og analoger
NO155137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av 2-(4-piperidyl)-1-(4-kinolyl)-etanon.
ATE74130T1 (de) Pro-drug-derivate vom kardiotonischen agenz 4ethyl-1,3-dihydro-5(4-(2-methyl-1h-imidazol-1-y )-benzoyl>>-2h-imidazol-one.
NO891046D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
NL194463B (nl) Farmaceutisch preparaat dat 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H- imidazool-1-yl)methyl]-4H-carbazool-4-on bevat.
DK520787D0 (da) Terapeutisk middel indeholdende propentofyllin eller derivater deraf til brug ved behandling af peptisk ulcus
FI930608A (fi) Nya farmaceutiska formulationer av 5-(2-klor-1-hydroxietyl)-4-metyltiazol
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
DK434789D0 (da) 3-piperidinyl-indazolderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende samme
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
ITMI913461A1 (it) Composizioni terapeutiche adatte per la somministrazione rettale contenenti come principio attivo uno o piu' tioesteri del glutatione
LV5046A3 (lv) 3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens
NO910890D0 (no) Mellomprodukt for fremstilling av nye derivater av ((4-(4-(4-fenyl-1-piperazinyl)fenoksymetyl)1,3-dioksolan-2-yl)metyl)-1h-imidazoler og -1h-1,2,4-triazoler.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties